Innova Captab Limited (NSE:INNOVACAP)

Market Cap	49.89B
Revenue (ttm)	12.44B
Net Income (ttm)	1.28B
Shares Out	57.22M
EPS (ttm)	22.41
PE Ratio	38.90
Forward PE	28.73
Dividend	n/a
Ex-Dividend Date	n/a

Volume	37,338
Average Volume	47,342
Open	889.00
Previous Close	871.85
Day's Range	875.50 - 905.95
52-Week Range	479.00 - 1,260.00
Beta	n/a
RSI	46.36
Earnings Date	May 29, 2025

About Innova Captab

Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally. The company provides contract development and manufacturing organization services to Indian pharmaceutical companies. It is also involved in the development, manufacture, and distribution of generic formulation products, including cephalosporins, proton pump inhibitor, anticholinergic and heparin NSAIDs, analgesics and antipyretic, anticold and antiallergic, antieme...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2005
• Employees: 1,600
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: INNOVACAP

Financial Performance

In 2024, Innova Captab's revenue was 12.44 billion, an increase of 15.02% compared to the previous year's 10.81 billion. Earnings were 1.28 billion, an increase of 35.95%.